Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-19

Clinical Trial Update: Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the relative bioavailability of an extemporaneous aprepitant suspension in adolescents for chemotherapy-induced nausea and vomiting, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aprepitant (aprepitant)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Nausea, Vomiting | Phase 2 | Status: TERMINATED